img click

slideshow

Recent News



arrowMay 5, 2011
Escape SCILL Interns to Attend ISSCR 9th Annual Meeting in Toronto.

arrowNovember 2, 2010
Escape secures exclusive worldwide rights from Stanford University for a novel Botox formulation.

arrowNovember 2, 2010
Escape secures exclusive license with Stanford University for a novel bone growth protein.

About Escape Therapeutics


Since its founding in 2006, Escape Therapeutics has dedicated itself to transforming healthcare through discovery, development, and commercialization of innovative stem cell-based curative therapeutics capable of relieving the suffering of children and adults inflicted with devastating diseases or injuries that are currently inadequately treated and/or incurable.

Headquartered in Silicon Valley, California, the company has built an elite team of Stanford-trained scientists with core expertise in stem cell immunology and genetic engineering. This has fueled a series of significant scientific advances over the past 4 years, bringing Escape only months away from the creation of the world's first universal pluripotent stem cell source. Escape's primary areas of focus include type I diabetes, acute myocardial infarction, and acute and chronic skin wounds.

2010 Escape Therapeutics, Inc. All rights reserved.

Website design by Sylvia Do & Chris Nye

img